Description
Oncovorin 50mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient is Vinblastine, a vinca alkaloid that works by interfering with the formation of microtubules, which are essential for cell division. By disrupting this process, Oncovorin inhibits the growth and proliferation of cancer cells. It is primarily indicated for the treatment of various malignancies, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and Kaposi’s sarcoma. The dosage and administration of Oncovorin 50mg Injection are determined by the patient’s specific condition, response to treatment, and other medical factors, and should only be prescribed and monitored by a qualified healthcare professional. Common side effects may include bone marrow suppression (leading to decreased blood cell counts), nausea, vomiting, constipation, hair loss, and peripheral neuropathy. Patients should be closely monitored for these adverse effects. Oncovorin 50mg Injection should be stored at room temperature, protected from light, and kept out of reach of children.
